Dipeptidyl peptidase-4 inhibition: linking chemical properties to clinical safety.

Matteucci, E; Giampietro, O

Matteucci, E; Giampietro, O.

Affiliation

Matteucci E; Department of Internal Medicine, University of Pisa, Italy. elena.matteucci@med.unipi.it

Curr Med Chem ; 18(31): 4753-60, 2011.

Article in En | MEDLINE | ID: mdl-21919850

Subject(s)

Diabetes Mellitus, Type 2/drug therapy; Dipeptidyl-Peptidase IV Inhibitors/therapeutic use; Hypoglycemic Agents/therapeutic use; Cardiovascular Diseases/etiology; Clinical Trials as Topic; Dipeptidyl-Peptidase IV Inhibitors/adverse effects; Dipeptidyl-Peptidase IV Inhibitors/chemistry; Dipeptidyl-Peptidase IV Inhibitors/pharmacology; Gastrointestinal Diseases/etiology; Humans; Hypoglycemic Agents/adverse effects; Hypoglycemic Agents/chemistry; Hypoglycemic Agents/pharmacology; Lipid Metabolism/drug effects; Peptidyl-Dipeptidase A/metabolism; Substrate Specificity

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / Hypoglycemic Agents Type of study: Etiology_studies Limits: Humans Language: En Journal: Curr Med Chem Journal subject: QUIMICA Year: 2011 Document type: Article Affiliation country: Italy Country of publication: United Arab Emirates

Search on Google

Add to My VHL

XML

PubMed Links